Dr. Maofu Fu M.D. PHD
Hematologist-Oncologist | Hematology & Oncology3001 Hospital Dr Hyattsville MD, 20785
Maofu Fu, MD, PhD, is an Associate Professor of Clinical Medicine in the section of Hematology and Oncology of the Department of Medicine at LSU Health New Orleans School of Medicine. Dr. Fu first obtained his bachelor?s degree of medicine at The First Military Medical University in Guangzhuo, China, in 1985 and then his PhD from Sun Yat-sen University of Medical Sciences (China, 1994). His postgraduate training encompasses his internal medicine residency at Prince George?s Hospital and also his clinical fellowship in hematology and medical oncology at Thomas Jefferson University Hospital (2009-2012). Dr. Fu is certified in internal medicine, oncology, and hematology by the American Board of Internal Medicine and is also an active member of the American Society of Clinical Oncology and the American College of Physicians.
Education and Training
First Military Medical University
American Board of Internal Medicine
Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology
Areas of expertise and specialization
Faculty Titles & Positions
- Teaches in the Fellowship Program -
- Associate Professor of Clinical Medicine, LSU Health Program -
- Prince Georges Hospital Center
- Prince Georges Hospital Center
- Thomas Jefferson University Hospital (Hematology, Oncology)
Professional Society Memberships
- American Society of Clinical Oncology, American College of Physicians
Articles and Publications
- 15 Publications
What do you attribute your success to?
- Many Years in Training in Cancer Research helping him to be able to help patients more fully explain to them how they got cancer and best treatments for them.
Hobbies / Sports
- Writing Chinese Poems
Dr. Maofu Fu M.D. PHD's Practice location
New Orleans, Louisiana 70112Get Direction
CLEARFIELD, PA 16830Get Direction
Hyattsville, MD 20785Get Direction
Dr. Maofu Fu M.D. PHD's reviewsWrite Review
Patient Experience with Dr. Fu
- New Diagnostic Tool Approved for Lymphoma
A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...
- Astonishing Clinical Trial Results Show Promise for Non-Hodgkin Lymphoma Research
There’s good news for those who’ve been diagnosed with the aggressive non-Hodgkin lymphoma (NHL) type referred to as diffuse large-B cell (DLBCL). According to the American Cancer Society (ACS), this type of HNL is the most common type of lymphoma.The descriptive letters clarify the type of...
- Tips for Young Adult Lymphoma Survivors to Make the Most of Recovery
It is extremely difficult to reenter the world and normal life after battling lymphoma. Recovery is much more than the body's physical battle, but how to balance emotions and relationships as well.However, there are specific tools that can assist in adapting back into a life that may seem...
- 'Robocop' Stem Cells Developed to Fight Cancer
Cancer is the second-leading cause of death in the United States, although due to several advancements in cancer screening and treatment, survival rates have begun to improve.A new cancer therapyResearchers at the University of Minnesota and Mayo Clinic have developed a new type of cancer therapy...
- What Specialists Treat Multiple Myeloma?
If you suffer from multiple myeloma, which a rare form of blood cancer, one of the most crucial decisions you will have to make is choosing a doctor who specializes in multiple myeloma. A hematologist-oncologist is the specialist you need who will manage your cancer throughout the cycle of...
- Promising Results for Hodgkin Patients Using This Therapy
Researcher Dr. Bradford S. Hoppe and his colleagues at the University of Florida College of Medicine have recently found that the addition of proton therapy to first-line chemotherapy regimens may improve outcomes for patients with Hodgkin lymphoma.Lymphoma is classically treated with both...